CHMA Chiasma Inc.

3.71
-0.07  -2%
Previous Close 3.78
Open 3.77
Price To Book 2.18
Market Cap 90637686
Shares 24,430,643
Volume 12,106
Short Ratio
Av. Daily Volume 78,187

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 completion of enrollment announced October 1, 2018 with data due September 2019.
Mycapssa - OPTIMAL
Acromegaly
CRL April 15 2016
Mycapssa
Acromegaly
Phase 3 data due 2H 2020.
Mycapssa - MPOWERED
Maintenance treatment of adult acromegaly

SEC Filings

  1. SC 13G - Statement of acquisition of beneficial ownership by individuals 181200949
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 181198892
  3. 424B5 - Prospectus [Rule 424(b)(5)] 181170203
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 181170112
  5. 8-K - Current report 181169956
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181005406
  7. 8-K - Current report 181005195
  8. 8-K - Current report 18892352
  9. 10-Q - Quarterly report [Sections 13 or 15(d)] 18822800
  10. 8-K - Current report 18822575